WebOct 11, 2024 · Weakening of the heart muscle (cardiomyopathy) Heart rhythm problems (arrhythmia) Heart attack Stroke High blood pressure Blood clots Whether you're at risk for heart problems during and after cancer treatment depends on how healthy your heart is and the specific drugs you'll be receiving. WebYes, your experiences are very helpful. It appears that your experiences about cisplatin, magnesium, kidney disease and high blood pressure are all accurate. Cisplatin can …
Recent Advances in Models, Mechanisms, Biomarkers, and
WebSep 15, 2024 · Cisplatin is the prototype platinum coordination complex classified as an alkylating agent and used intravenously in the treatment of several forms of cancer. … WebApr 11, 2024 · Currently, diminished levels of H 2 S have been reported to occur in hypertension [57,58], vascular inflammation in pulmonary hypertension , ... Cisplatin induced H 2 S formation in tissues and increased the expression of CSE in renal tissues of animals . Moreover, the inhibition of CSE using DL-propargylglycine (PAG) prevented … dys means
Novel Insights on Lipid Metabolism Alterations in Drug Resistance …
WebKeywords: PRES; RPLS; Encephalopathy; Cisplatin; Hypertension . 1. Introduction . Cisplatin, a platinum compound, is one of the most bro- adly used chemotherapeutic agents. Since its introduction in the 1970s Cisplatin has become a cornerstone for many of the anti-cancer regimens in a variety of malignancies. WebNov 23, 2024 · Hypertension develops in up to 43% of patients taking VSP inhibitors. 43, 44 A recent meta-analysis found that bevacizumab use is associated with a higher risk of high-grade hypertension (RR, 5.28 [95% CI, 4.15–6.71]). 45 The effect of bevacizumab on hypertension is dose dependent: the reported RR for a low drug dose (3.5–7.5 mg/kg … WebMay 13, 2024 · Recently, ACC is emphasized in cancer chemoresistance. In cisplatin-resistant lung cancer cells which had high ROS and low thioredoxin-1 (TRX1) levels, ACC presented a significantly high basal level (Wangpaichitr et al., 2012). The up-regulation of the antioxidative factor TRX1 caused an attenuated level of ACC (Wangpaichitr et al., … csc dcc specifications